IGM Biosciences (IGMS) PT Lowered to $15 at Morgan Stanley
Tweet
Share
E-mailGet Alerts IGMS Hot Sheet
Price: $1.27 --0%
Rating Summary:
3 Buy, 8 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 9
Rating Summary:
3 Buy, 8 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 9
Join SI Premium – FREE
Morgan Stanley analyst Michael Ulz lowered the price target on IGM Biosciences (NASDAQ: IGMS) to $15.00 (from $20.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- TerraVest Industries Inc (TVK:CN) PT Raised to Cdn$170 at BMO Capital
- CrowdStrike (CRWD) PT Raised to $256 at RBC Capital
- SanDisk (SNDK) PT Raised to $1,600 at RBC Capital
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
